Putting Their Health In Their Hands: Enhancing Respiratory Patient Outcomes Through Digital Therapeutics
Pressurized metered dose inhalers (pMDI) are convenient and effective devices for the symptomatic relief and sustained management of Asthma and Chronic Obstructive Pulmonary Disease (COPD). Partly due to the propellant gases in pMDIs, there is a need to develop low carbon impact inhalers, also known as more sustainable inhaler devices, in the strive towards a more sustainable healthcare sector.
Subscribe to Email Updates
Submit your email address below and stay up to date with the latest industry insights.
*Required. For details about how your email address will be used, read our General Terms and Conditions of Use, Privacy and Cookies Policy.